Mark W. Lingen to Piperazines
This is a "connection" page, showing publications Mark W. Lingen has written about Piperazines.
Connection Strength
0.019
-
The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma. Cancer Res. 2009 Apr 01; 69(7):3021-31.
Score: 0.019